Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data

Abstract Background Neoadjuvant therapy can lead to different tumor regression grades (TRG) in rectal cancer after neoadjuvant therapy. The purposes of this study are to investigate the relationships among TRG, pathologic complete response (pCR) and long-term survival, on the basis of reconstructed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jia-yi Li, Xuan-zhang Huang, Peng Gao, Yong-xi Song, Xiao-wan Chen, Xing-er Lv, Yv Fu, Qiong Xiao, Shi-yv Ye, Zhen-ning Wang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/4954ec4b091b4a899a745afe74bf1b92
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4954ec4b091b4a899a745afe74bf1b92
record_format dspace
spelling oai:doaj.org-article:4954ec4b091b4a899a745afe74bf1b922021-11-14T12:29:54ZSurvival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data10.1186/s12885-021-08922-11471-2407https://doaj.org/article/4954ec4b091b4a899a745afe74bf1b922021-11-01T00:00:00Zhttps://doi.org/10.1186/s12885-021-08922-1https://doaj.org/toc/1471-2407Abstract Background Neoadjuvant therapy can lead to different tumor regression grades (TRG) in rectal cancer after neoadjuvant therapy. The purposes of this study are to investigate the relationships among TRG, pathologic complete response (pCR) and long-term survival, on the basis of reconstructed individual patient data (IPD). Methods The PubMed, Embase, Ovid and Cochrane CENTRAL databases were searched. The primary endpoint was to evaluate the survival landscape of different TRGs after neoadjuvant therapy and the secondary endpoint was to evaluate the associations between pCR and survival. IPD were reconstructed with Kaplan–Meier curves. Results The 10-year overall survival (OS) and 5-year disease-free survival (DFS) were clearly higher in the pCR group than in the non-pCR (npCR) group (80.5% vs. 48.3, 90.1% vs. 69.8%). Furthermore, the OS and DFS increased with improvement in tumor regression after neoadjuvant therapy. According to the IPD, the pCR group had longer OS (HR = 0.240, 95% CI = 0.177–0.325, p < 0.001) and DFS (HR = 0.274, 95% CI = 0.205–0.367, p < 0.001) than the npCR group. Better tumor regression was associated with better survival outcomes (p < 0.005). Direct calculation of published HR values yielded similar results. Conclusions Our results indicate a positive relationship between better tumor regressions and improved survival benefits among the npCR group and patients with rectal cancer achieving pCR had much longer OS and DFS than patients achieving npCR, presenting a survival landscape of different TRGs and pCR in rectal cancer after neoadjuvant therapy.Jia-yi LiXuan-zhang HuangPeng GaoYong-xi SongXiao-wan ChenXing-er LvYv FuQiong XiaoShi-yv YeZhen-ning WangBMCarticleRectal cancerNeoadjuvant therapyPathological complete responseTumor regression gradeSurvivalNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Rectal cancer
Neoadjuvant therapy
Pathological complete response
Tumor regression grade
Survival
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Rectal cancer
Neoadjuvant therapy
Pathological complete response
Tumor regression grade
Survival
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Jia-yi Li
Xuan-zhang Huang
Peng Gao
Yong-xi Song
Xiao-wan Chen
Xing-er Lv
Yv Fu
Qiong Xiao
Shi-yv Ye
Zhen-ning Wang
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
description Abstract Background Neoadjuvant therapy can lead to different tumor regression grades (TRG) in rectal cancer after neoadjuvant therapy. The purposes of this study are to investigate the relationships among TRG, pathologic complete response (pCR) and long-term survival, on the basis of reconstructed individual patient data (IPD). Methods The PubMed, Embase, Ovid and Cochrane CENTRAL databases were searched. The primary endpoint was to evaluate the survival landscape of different TRGs after neoadjuvant therapy and the secondary endpoint was to evaluate the associations between pCR and survival. IPD were reconstructed with Kaplan–Meier curves. Results The 10-year overall survival (OS) and 5-year disease-free survival (DFS) were clearly higher in the pCR group than in the non-pCR (npCR) group (80.5% vs. 48.3, 90.1% vs. 69.8%). Furthermore, the OS and DFS increased with improvement in tumor regression after neoadjuvant therapy. According to the IPD, the pCR group had longer OS (HR = 0.240, 95% CI = 0.177–0.325, p < 0.001) and DFS (HR = 0.274, 95% CI = 0.205–0.367, p < 0.001) than the npCR group. Better tumor regression was associated with better survival outcomes (p < 0.005). Direct calculation of published HR values yielded similar results. Conclusions Our results indicate a positive relationship between better tumor regressions and improved survival benefits among the npCR group and patients with rectal cancer achieving pCR had much longer OS and DFS than patients achieving npCR, presenting a survival landscape of different TRGs and pCR in rectal cancer after neoadjuvant therapy.
format article
author Jia-yi Li
Xuan-zhang Huang
Peng Gao
Yong-xi Song
Xiao-wan Chen
Xing-er Lv
Yv Fu
Qiong Xiao
Shi-yv Ye
Zhen-ning Wang
author_facet Jia-yi Li
Xuan-zhang Huang
Peng Gao
Yong-xi Song
Xiao-wan Chen
Xing-er Lv
Yv Fu
Qiong Xiao
Shi-yv Ye
Zhen-ning Wang
author_sort Jia-yi Li
title Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
title_short Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
title_full Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
title_fullStr Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
title_full_unstemmed Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
title_sort survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
publisher BMC
publishDate 2021
url https://doaj.org/article/4954ec4b091b4a899a745afe74bf1b92
work_keys_str_mv AT jiayili survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT xuanzhanghuang survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT penggao survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT yongxisong survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT xiaowanchen survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT xingerlv survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT yvfu survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT qiongxiao survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT shiyvye survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
AT zhenningwang survivallandscapeofdifferenttumorregressiongradesandpathologiccompleteresponseinrectalcancerafterneoadjuvanttherapybasedonreconstructedindividualpatientdata
_version_ 1718429163885428736